Abstract
Nasal polyps, a chronic inflammatory disease occurring in the nose and para-nasal sinuses, result from several different causes, including cystic fibrosis (CF). Forty-four patients affected by nasal polyps were admitted to the Department of Otolaryngology, Lublin University School of Medicine, Lublin, Poland, and screened for the most-commonly identified CFTR mutations [ΔF508, G542X, N1303 K, 1717–1 (G to A), W1282X, G551D, R553X and ΔI507] by applying the INNO-LIPA CF2 test strips. None of the patients had symptoms that allowed for the diagnosis of CF, including the negative sweat test. We detected 5 of 44 (11.4%) carriers of the CFTR mutations. All patients positive for this test were heterozygous carriers of ΔF508. In the control group, only 1 of 70 (1.4%) cases showed ΔF508 heterozygosity. The frequency of ΔF508 mutation herein reported was significantly higher than in the control group ( P =0.0312) and in the general Polish population as well ( P =0.0059). Our data suggest that a heterozygous manifestation of the ΔF508 may exist in a selected group of patients affected by nasal polyps, who have no other clinical features of CF.
Similar content being viewed by others
References
Aitken ML, Fiel SB (1993) Cystic fibrosis. Dis Mon 39:1–52
Anguiano A, Oates RD, Amos JA, Dean M, Gerrard B, Stewart C, Maher TA, White MB, Milunsky A (1992) Congenital bilateral absence of the vas deferens. A primarily genital form of cystic fibrosis. JAMA 267:1794–1797
Bateman ND, Fahy C, Woolford TJ (2003) Nasal polyps: still more questions than answers. J Laryngol Otol 117:1–9
Bernstein JM (2001) The molecular biology of nasal polyposis. Curr Allergy Asthma Rep 1:262–267
Bozkowa K, Siwinska-Golebiowska H, Rutkowska J, Nowakowska A, Holzer J (1971) Epidemiology of mucoviscidosis in children in Poland (in Polish). Pediatr Pol 46:677–684
Brezillon S, Dupuit F, Hinnrasky J, Marchand V, Kalin N, Tummler B, Puchelle E (1995) Decreased expression of the CFTR protein in remodeled human nasal epithelium from non-cystic fibrosis patients. Lab Invest 72:191–200
Bucholtz GA, Ejercito VS, Burmester JK (1999) The cystic fibrosis conductance regulator gene exon sequence is normal in a patient with edematous eosinophilic nasal polyps. Am J Rhinol 13:221–223
Burger J, Macek M Jr, Stuhrmann M, Reis A, Krawczak M, Schmidtke J (1991) Genetic influences in the formation of nasal polyps. Lancet 337:974
Cimmino M, Cavaliere M, Nardone M, Plantulli A, Orefice A, Esposito V, Raia V (2003) Clinical characteristics and genotype analysis of patients with cystic fibrosis and nasal polyposis. Clin Otolaryngol 28:125–132
Dupuit F, Kalin N, Brezillon S, Hinnrasky J, Tummler B, Puchelle E (1995) CFTR and differentiation markers expression in non-CF and ΔF508 homozygous CF nasal epithelium. J Clin Invest 95:1601–1611
Gentile VG, Isaacson G (1996) Patterns of sinusitis in cystic fibrosis. Laryngoscope 106:1005–1009
Harris A, Argent BE (1993) The cystic fibrosis gene and its product CFTR. Sem Cell Biol 4:37–44
Henriksson G, Westrin KM, Karpati F, Wikstrom A-C, Stierna P, Hjelte L (2002) Nasal polyps in cystic fibrosis. Clinical endoscopic study with nasal lavage fluid analysis. Chest 121:40–47
INNO-LIPA CF2 (1996) Part 2, Procedure by Innogenetics, N.V., Zwijndrecht, Belgium
Irving RM, McMahon R, Clark R, Jones NS (1997) Cystic fibrosis transmembrane conductance regulator gene mutations in severe nasal polyposis. Clin Otolaryngol 22:519–521
Jorissen MB, De Boeck K, Cuppens H (1999) Genotype-phenotype correlations for the paranasal sinuses in cystic fibrosis. Am J Respir Crit Care Med 159:1412–1416
Keller JJ, Westerman AM, Rooij FWM, Wilson JHP, Dekken H, Giardiello FM, Weterman MAJ, Offerhaus JA (2004) Molecular genetic evidence of an association between nasal polyposis and the Peutz-Jeghers syndrome. Ann Int Med 136:855–856
Kerem B-S, Rommens JM, Buchanan JA, Markiewicz D, Cox TIC, Chakravati A, Buchwald M, Tsui L-C (1989) Identification of the cystic fibrosis gene: genetic analysis. Science 245:1073–1080
Kingdom TT, Lee KC, FitzSimmons SC, Cropp GJ (1996) Clinical characteristics and genotype analysis of patients with cystic fibrosis and nasal polyposis requiring surgery. Arch Otolaryngol Head Neck Surg 122:1209–1213
Kostuch M, Semczuk A, Szarewicz-Adamczyk W, Gasowska-Giszczak U, Wojcierowski J, Kulczycki L (2000) Detection of CFTR gene mutations in patients suffering from chronic bronchitis. Arch Med Res 31:97–100
Kostuch M, Rudzki S, Semczuk A, Kulczycki L (2002) CFTR gene mutations in patients suffering from acute pancreatitis. Med Sci Monit 8:BR369–372
Kuchynkowa Z, Macek M Jr, Holcat M, Macek M (1995) Detection of mutation G551D mutation in a patient with nasal polyps (in Czech). Cas Lek Ces 134:212–213
Kulczycki LL, Butler JS, McCord-Dickman D, Herer GR (1970) The hearing of patients with cystic fibrosis. Arch Otolaryngol 92:54–59
Kulczycki LL, Herer GR, Butler JS (1970) Cystic fibrosis and hearing. Integrity of the upper respiratory tract as related to hearing sensitivity. Clin Pediatr 9:390–402
Kulczycki LL, Kostuch M, Bellanti JA (2003) A clinical perspective of cystic fibrosis and new genetic findings: Relationship of CFTR mutations to genotype-phenotype manifestations. Am J Med Genet 116A:262–267
Luxenberger W, Posch U, Berghold A, Hofmann T, Lang-Loidolt D (2000) HLA patterns in patients with nasal polyposis. Eur Arch Otorhinolaryngol 257:137–139
Mercier B, Verlingue C, Lissens W, Silber SJ, Novelli G, Bonduelle M, Audrezet MP, Ferec C (1995) Is congenital bilateral absence of vas deferens a primary form of cystic fibrosis? Analyses of the CFTR gene in 67 patients. Am J Hum Genet 56:272–277
Multiple amplification of 4 exons of the CFTR gene. Part 1. Procedure by Innogenetics N.V., Zwijndrecht, Belgium, 1996
Pawankar R (2003) Nasal polyposis: an update. Curr Opin Allergy Clin Immunol 3:1–6
Riordan JR, Rommens JM, Kerem D, Alon N, Rozmahel R, Grzelczak Z, Zielenski J, Lok S, Plavsic N, Chou JL, Drumm ML, Iannuzzi MC, Collins FS, Tsui L-C (1989) Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 245:1066–1073
Rommens JM, Iannuzzi MC, Kerem B, Drumm ML, Melmer GD, Dean M, Rozmahel R, Cole JL, Kemmedy D, Hidaka N, Buchwald M, Riordan JR, Tsui L-C, Collins FS (1989) Identification of the cystic fibrosis gene: chromosome walking and jumping. Science 245:1059–1065
Rosenstein BJ, Zeitlin PL (1998) Cystic fibrosis. Lancet 351:277–282
Semczuk M, Kostuch M, Krzyzanowski A, Kwasniewska A, Wojcierowski J (1998) The detection of CFTR gene mutations in patients with azoospermia (in Polish). Gin Pol 69:506–511
Settipane GA (1996) Epidemiology of nasal polyps. Allergy Asthma Proc 17:231–236
Varon R, Magdorf K, Staab D, Wahn H-U, Krawczak M, Sperling K, Reis A (1995) Recurrent nasal polyps as a monosymptomatic form of cystic fibrosis associated with a novel in-frame deletion (591del18) in the CFTR gene. Hum Mol Genet 8:1463–1464
Wang XJ, Moylan B, Leopold DA, Kim J, Rubenstein RC, Togias A, Proud D, Zeitlin PL, Cutting GR (2000) Mutation in the gene responsible for cystic fibrosis and predisposition to chronic rhinosinusitis in the general population. JAMA 284:1814–1819
Acknowledgments
Financial support from the Lublin University School of Medicine, Lublin, Poland, is gratefully acknowledged.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kostuch, M., Klatka, J., Semczuk, A. et al. Analysis of most common CFTR mutations in patients affected by nasal polyps. Eur Arch Otorhinolaryngol 262, 982–986 (2005). https://doi.org/10.1007/s00405-005-0927-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00405-005-0927-0